Technology from computing powerhouse Nvidia is already hard at work inside companies at the convergence of technology and biology, including the supercomputer driving Recursion Pharmaceutical’s drug ...
The artificial-intelligence-powered drug designer Recursion signed on to a wide-ranging collaboration with Roche and its Genentech division. Starting with a hefty $150 million upfront payment, the ...
(RTTNews) - Biotechnology company Recursion (RXRX) announced Tuesday a collaboration with Roche holding AG (ROG, RHHBY) and Genentech, a member of the Roche Group, to advance novel medicines to ...
Recursion Pharmaceuticals (RXRX) saw a sharp uptick in trading as investors looked ahead to the CEO's upcoming presentation at a major AI conference. The focus is on how the company’s AI strategy and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback